Journal of Menopausal Medicine

作者署名资格基于以下四项条件：对研究构思设计、数据获取或分析解释有实质性贡献；撰写论文或对其进行重要学术内容方面的批判性修改；对拟发表版本作最终批准；同意对工作中所有方面负责，确保与准确性或完整性相关的问题得到适当调查和解决。所有共同作者均应满足这四项条件。 模型中文摘要

Authorship credit should be assigned on the basis of the following: 1) substantial contributions to study conception and design, acquisition of data, or analysis and interpretation of data; 2) drafting the article or revising it critically for important intellectual content; 3) final approval of the version to be published; and 4) agreement to be accountable for all aspects of the work in ensuring…

通讯作者应告知编辑可能影响数据解释的作者潜在利益冲突；即使作者确信其判断未受影响，潜在利益冲突也应在投稿信中披露；此类冲突可能包括来自制药公司的经济资助或私人关系、利益集团的政治压力或学术问题；披露表与ICMJE利益冲突表相同。 模型中文摘要

The corresponding author of an article is asked to inform the editor of the authors’ potential conflicts of interest, which might influence their interpretation of data. A potential conflict of interest should be disclosed in the cover letter even when the authors are confident that their judgments have not been influenced in preparing the manuscript. Such conflicts may be financial support or pri…

本期刊遵循《临床试验数据共享声明：国际医学期刊编辑委员会的要求》中所述的数据共享政策。 模型中文摘要

This journal follows the data sharing policy described in “Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors.”

《绝经医学杂志》将遵循出版伦理委员会（COPE）建立的流程图来处理任何涉嫌学术不端行为。 模型中文摘要

The Journal of Menopausal Medicine (JMM) will follow the flowchart established by the Committee on Publication Ethics (COPE, http://publicationethics.org/resources/flowcharts) for settlement of any alleged misconduct.

所有已发表论文成为韩国绝经学会的永久财产，未经书面许可不得在其他地方发表；版权转让表可在稿件提交页面获取并可电子提交；这些政策遵循知识共享署名-非商业性使用许可（CC BY-NC 4.0）。 模型中文摘要

All published papers become the permanent property of the Korean Society of Menopause and must not be published elsewhere without written permission. A copyright transfer form is readily available on the manuscript submission page (https://www.editorialmanager.com/jmenopausalmed/default2.aspx) and can be completed and submitted electronically. These policies follow the Creative Commons Attribution…

所有稿件将由编辑选定的同行评审人员进行评审；接受标准基于研究的质量、原创性及其临床和科学意义；在评审人员同意评审后通常4周内作出初步决定，评审意见随后发送给通讯作者；修改稿必须由通讯作者在线提交，并逐项说明对评审意见的修改。 模型中文摘要

All manuscripts will be evaluated by peer reviewers who are selected by the editors. The acceptance criteria for all papers are based on the quality and originality of the research and its clinical and scientific significance. An initial decision will normally be made within 4 weeks after the agreement of review by the reviewers, and the reviewers’ comments will then be sent to the corresponding a…

在投稿之前将使用CrossCheck或eTBLAST检查重复（抄袭）。 模型中文摘要

Duplication will be checked using CrossCheck (https://app.ithenticate.com/) or eTBLAST (http://etest.vbi.vt.edu/etblast3) prior to submission.

Preprint policy: preprints on MedRxiv, researchsquare, bioRxiv not considered duplicate publication under conditions. 模型摘要

JMM allows a paper that has not conducted peer review on a preprint server such as the MedRxiv, researchsquare, and bioRxiv will not be considered as a duplicate publication, provided that the following conditions are met: 1) During submission, authors must acknowledge preprint server deposition and provide any associated accession numbers or Digital Object Identifiers (DOIs) and a link to the pre…

JMM全文已存档于PubMed Central（PMC）；作者不能存档预印本（即评审前版本），但可以存档后印本（即评审后最终稿）；作者可以存档出版商版本/PDF。 模型中文摘要

The full text of JMM has been archived in PubMed Central (PMC). Authors cannot archive pre-print (i.e., pre-refereeing), but they can archive post-print (i.e., final draft post-refereeing). Authors can archive the publisher’s version/PDF.

任何涉及临床试验的研究应在主要国家临床试验注册网站（如http://cris.nih.go.kr/cris/index.jsp）或经世界卫生组织或ICMJE认可的其他网站注册。 模型中文摘要

Any research that deals with clinical trial should be registered with the primary national clinical trial registration site such as http://cris.nih.go.kr/cris/index.jsp, or other sites accredited by World Health Organization or ICMJE